Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a metadata-only update to the page. No substantive study content or functionality changes are indicated.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than a change to the study details.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now shows Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.1%

- Check93 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This appears to be a minor page update.SummaryDifference0.1%

- Check115 days agoChange Detected- Updated page revision tag from v3.4.1 to v3.4.2; no impact on study content or user workflow.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.